These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31082400)

  • 1. FGF-2 targets sclerostin in bone and myostatin in skeletal muscle to mitigate the deleterious effects of glucocorticoid on musculoskeletal degradation.
    Adhikary S; Choudhary D; Tripathi AK; Karvande A; Ahmad N; Kothari P; Trivedi R
    Life Sci; 2019 Jul; 229():261-276. PubMed ID: 31082400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
    Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
    Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid aggravates bone micro-architecture deterioration and skeletal muscle atrophy in mice fed on high-fat diet.
    Adhikary S; Kothari P; Choudhary D; Tripathi AK; Trivedi R
    Steroids; 2019 Sep; 149():108416. PubMed ID: 31150681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
    Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
    Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of glutamine on prevention of glucocorticoid-induced skeletal muscle atrophy is associated with myostatin suppression.
    Salehian B; Mahabadi V; Bilas J; Taylor WE; Ma K
    Metabolism; 2006 Sep; 55(9):1239-47. PubMed ID: 16919545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss.
    Wang FS; Ko JY; Yeh DW; Ke HC; Wu HL
    Endocrinology; 2008 Apr; 149(4):1793-801. PubMed ID: 18174290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-29a mitigates glucocorticoid induction of bone loss and fatty marrow by rescuing Runx2 acetylation.
    Ko JY; Chuang PC; Ke HJ; Chen YS; Sun YC; Wang FS
    Bone; 2015 Dec; 81():80-88. PubMed ID: 26141838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy.
    Gilson H; Schakman O; Combaret L; Lause P; Grobet L; Attaix D; Ketelslegers JM; Thissen JP
    Endocrinology; 2007 Jan; 148(1):452-60. PubMed ID: 17038559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-α on osteoblast marker expression induced by bone morphogenetic protein-2.
    Katsuyama T; Otsuka F; Terasaka T; Inagaki K; Takano-Narazaki M; Matsumoto Y; Sada KE; Makino H
    Peptides; 2015 Nov; 73():88-94. PubMed ID: 26409788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice.
    Nakamura Y; Tensho K; Nakaya H; Nawata M; Okabe T; Wakitani S
    Bone; 2005 Mar; 36(3):399-407. PubMed ID: 15777655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength.
    Yao W; Dai W; Jiang L; Lay EY; Zhong Z; Ritchie RO; Li X; Ke H; Lane NE
    Osteoporos Int; 2016 Jan; 27(1):283-294. PubMed ID: 26384674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dicer ablation in osteoblasts by Runx2 driven cre-loxP recombination affects bone integrity, but not glucocorticoid-induced suppression of bone formation.
    Liu P; Baumgart M; Groth M; Wittmann J; Jäck HM; Platzer M; Tuckermann JP; Baschant U
    Sci Rep; 2016 Aug; 6():32112. PubMed ID: 27554624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myostatin inhibits osteoblastic differentiation by suppressing osteocyte-derived exosomal microRNA-218: A novel mechanism in muscle-bone communication.
    Qin Y; Peng Y; Zhao W; Pan J; Ksiezak-Reding H; Cardozo C; Wu Y; Divieti Pajevic P; Bonewald LF; Bauman WA; Qin W
    J Biol Chem; 2017 Jun; 292(26):11021-11033. PubMed ID: 28465350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone-induced skeletal muscle atrophy was associated with upregulation of myostatin promoter activity.
    Qin J; Du R; Yang YQ; Zhang HQ; Li Q; Liu L; Guan H; Hou J; An XR
    Res Vet Sci; 2013 Feb; 94(1):84-9. PubMed ID: 22939086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression.
    Ma K; Mallidis C; Bhasin S; Mahabadi V; Artaza J; Gonzalez-Cadavid N; Arias J; Salehian B
    Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E363-71. PubMed ID: 12721153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential growth factor control of bone formation through osteoprogenitor differentiation.
    Chaudhary LR; Hofmeister AM; Hruska KA
    Bone; 2004 Mar; 34(3):402-11. PubMed ID: 15003788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells.
    Matsumoto Y; Otsuka F; Takano M; Mukai T; Yamanaka R; Takeda M; Miyoshi T; Inagaki K; Sada KE; Makino H
    Mol Cell Endocrinol; 2010 Aug; 325(1-2):118-27. PubMed ID: 20638987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-29a protects against glucocorticoid-induced bone loss and fragility in rats by orchestrating bone acquisition and resorption.
    Wang FS; Chuang PC; Lin CL; Chen MW; Ke HJ; Chang YH; Chen YS; Wu SL; Ko JY
    Arthritis Rheum; 2013 Jun; 65(6):1530-40. PubMed ID: 23529662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerostin vaccination mitigates estrogen deficiency induction of bone mass loss and microstructure deterioration.
    Wang FS; Wu RW; Lain WS; Tsai TC; Chen YS; Sun YC; Ke HJ; Li JC; Hwang J; Ko JY
    Bone; 2018 Jul; 112():24-34. PubMed ID: 29653294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock protein 60 protects skeletal tissue against glucocorticoid-induced bone mass loss by regulating osteoblast survival.
    Wang FS; Wu RW; Ko JY; Tai MH; Ke HC; Yeh DW; Wu SL; Chen MW
    Bone; 2011 Nov; 49(5):1080-9. PubMed ID: 21854881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.